Asthma & COPD Global Market 2018: Key Players – GSK, Novartis, Merck, Abbott, Boehringer Ingelheim
Description
Wiseguyreports.Com Adds “Asthma & COPD -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database
This report studies the global Asthma & COPD market status and forecast, categorizes the global Asthma & COPD market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Chronic obstructive pulmonary disease (COPD) is a general term that describes progressive respiratory diseases like emphysema and chronic bronchitis. COPD is characterized by decreased airflow over time, as well as inflammation of the tissues that line the airway.
Asthma is usually considered a separate respiratory disease, but sometimes it’s mistaken for COPD. The two have similar symptoms. These symptoms include chronic coughing, wheezing, and shortness of breath.
Currently, North America leads the global market for asthma & COPD drugs and devices. North America was followed by Europe in terms of market capitalization. However, North America and Europe is expected to lose out some of the market share to other emerging regional markets owing to the expiry of several patens of pharmaceutical companies operating in these regions. Asia Pacific is expected to be the fastest regional market for asthma and COPD owing to the increased incidence of asthma & other respiratory diseases in industrial regions.
The major manufacturers covered in this report
GSK
Novartis
Merck
Abbott
Boehringer Ingelheim
AstraZeneca
Roche
Teva
Vectura
Pfizer
Mylan
Allergan
Cipla
Akorn
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3317833-global-asthma-copd-market-research-report-2018
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Anti-inflammatory Drugs
Bronchodilator Monotherapy
Combination Drugs
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Asthma & COPD Manufacturers
Asthma & COPD Distributors/Traders/Wholesalers
Asthma & COPD Subcomponent Manufacturers
Industry Association
Downstream Vendors
Leave a Query @ https://www.wiseguyreports.com/enquiry/3317833-global-asthma-copd-market-research-report-2018
Table of Contents
Global Asthma & COPD Market Research Report 2018
1 Asthma & COPD Market Overview
1.1 Product Overview and Scope of Asthma & COPD
1.2 Asthma & COPD Segment by Type (Product Category)
1.2.1 Global Asthma & COPD Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Asthma & COPD Production Market Share by Type (Product Category) in 2017
1.2.3 Anti-inflammatory Drugs
1.2.4 Bronchodilator Monotherapy
1.2.5 Combination Drugs
1.3 Global Asthma & COPD Segment by Application
1.3.1 Asthma & COPD Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Drug Stores
1.3.5 Retail Pharmacies
1.3.6 E-Commerce
1.4 Global Asthma & COPD Market by Region (2013-2025)
1.4.1 Global Asthma & COPD Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Asthma & COPD (2013-2025)
1.5.1 Global Asthma & COPD Revenue Status and Outlook (2013-2025)
1.5.2 Global Asthma & COPD Capacity, Production Status and Outlook (2013-2025)
....
7 Global Asthma & COPD Manufacturers Profiles/Analysis
7.1 GSK
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Asthma & COPD Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 GSK Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Novartis
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Asthma & COPD Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Novartis Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Merck
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Asthma & COPD Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Merck Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Abbott
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Asthma & COPD Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Abbott Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Boehringer Ingelheim
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Asthma & COPD Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Boehringer Ingelheim Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 AstraZeneca
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Asthma & COPD Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 AstraZeneca Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Roche
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Asthma & COPD Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Roche Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Teva
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Asthma & COPD Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Teva Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Vectura
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Asthma & COPD Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Vectura Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Pfizer
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Asthma & COPD Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Pfizer Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
7.10.4 Main Business/Business Overview
7.11 Mylan
7.12 Allergan
7.13 Cipla
7.14 Akorn
Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3317833
Continued...
Contact Us: [email protected] Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Posted by
Vivian Dsena
on Thursday August 02 2018, 10:16 AM EST.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
